How to measure (or not) compliance to eradication therapy

This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients’ reports. Experienced adverse drug reactions, perceived be...

Full description

Bibliographic Details
Main Authors: MArtins AP, Ferreira AP, Costa FA, Cabrita J
Format: Article
Language:English
Published: Centro de Investigaciones y Publicaciones Farmaceuticas 2006-06-01
Series:Pharmacy Practice
Subjects:
Online Access:http://www.pharmacypractice.org/vol04/02/088-094.htm
Description
Summary:This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients’ reports. Experienced adverse drug reactions, perceived benefit of therapy and quality of life were also measured. Mean compliance proportion was 56% and a positive impact on patients’ perceived health status was found. The method used was welcomed by community pharmacists, albeit having an influence on patients’ normal behaviour.
ISSN:1885-642X
1886-3655